Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Cardioangiologisches Centrum Bethanien clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Germany register with Cardioangiologisches Centrum Bethanien as lead sponsor. Synced 12 Nov 2026
4Current trials
4Recruiting now
0Drugs in these trials
1Trial register
At a glance

Cardioangiologisches Centrum Bethanien is the lead sponsor of 4 current clinical trials in our Germany register. 4 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Treatment of Atrial Fibrilation.

ClinicalTrials.gov trials by status

  • Recruiting4100%

Trials by phase

  • Not applicable375%
  • Observational125%
01

Clinical trials sponsored by Cardioangiologisches Centrum Bethanien

4 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
REal-world Valued Outcomes of a noveL Balloon-in-basket pUlsed Field ablaTION Catheter for Atrial Fibrillation RegistrY
NCT07459387 · ClinicalTrials.gov ↗ · Treatment of Atrial Fibrilation, Symptomatic Atrial Fibrillation
Not applicable Recruiting 2025-10 Germany
Electroporation Treatment for Early AF Management in Heart Failure With Preserved Ejection Fraction (HFpEF) Pilot Study
NCT07385417 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF)
Not applicable Recruiting 2023-04 Germany
REFOCUS-AF - "RepEat Ablation With AFFERA vs. COntact Force-Guided RF Catheters for Optimal OUtcomes in Symptomatic AF".
NCT07390214 · ClinicalTrials.gov ↗ · Atrial Fibrillation - Symptomatic
Not applicable Recruiting 2025-12 Germany
Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or Infection- or Vaccine-associated or Recurrent Venous and/or Arterial Thrombosis
NCT06650826 · ClinicalTrials.gov ↗ · Arterial or Venous Thrombosis
Observational Recruiting 2024-07 Germany

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Cardioangiologisches Centrum Bethanien trials

5 conditions
Treatment of Atrial Fibrilation1Symptomatic Atrial Fibrillation1Atrial Fibrillation (AF)1Atrial Fibrillation - Symptomatic1Arterial or Venous Thrombosis1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Germany44

A trial with sites in more than one country appears in each of those registers.

04

Questions about Cardioangiologisches Centrum Bethanien trials

How many clinical trials does Cardioangiologisches Centrum Bethanien sponsor?

Cardioangiologisches Centrum Bethanien is the lead sponsor of 4 current trials on ClinicalTrials.gov in our Germany register, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.

Are Cardioangiologisches Centrum Bethanien trials recruiting?

Yes. 4 of its 4 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.